Ernexa Therapeutics Inc. (ERNA) vs Pulmatrix, Inc. (PULM)
Ernexa Therapeutics Inc. and Pulmatrix, Inc. are both Biotechnology companies. Ernexa Therapeutics Inc. and Pulmatrix, Inc. are of similar size ($6.1M and $5.9M). Pulmatrix, Inc. grew revenue faster over the last twelve months: 6.96% against −78.6%. Across the 13 metrics below, Pulmatrix, Inc. leads on 10 and Ernexa Therapeutics Inc. on 3.
Valuation
Profitability
| Metric | ERNA | PULM | Biotechnology median |
|---|---|---|---|
| Gross margin | 83.51% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (321.22%) | (111.99%) | (57.72%) |
| Return on assets | (176.62%) | (85.74%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack